Breaking News Instant updates and real-time market news.

LBTYA

Liberty Global

$22.05 /

-0.13 (-0.59%)

, LBTYK

Liberty Global

$21.45 /

-0.16 (-0.74%)

05:39
08/12/20
08/12
05:39
08/12/20
05:39

Liberty Global to acquire Sunrise Communications Group for CHF110 per share

Liberty Global said in a release, "pursuant to the terms of a transaction agreement between Liberty Global and Sunrise Communications Group AG, Liberty Global has agreed to make an all cash public tender offer for all publicly held shares of Sunrise at a price of CHF110 per share. The offer represents a 32% premium to the 60-day volume weighted average price, or VWAP, per share of CHF83.17 during the period up to (and including) August 11 and values 100% of Sunrise's equity at CHF5 billion, representing a total enterprise value of CHF6.8 billion. Sunrise's Board of Directors is unanimously recommending that its shareholders accept the offer; Freenet AG, Sunrise's largest shareholder, which holds approximately 24% of Sunrise's capital, has signed a binding, unconditional commitment to tender its shares at the offer price. Attractive acquisition valuation for both parties representing 7.5x adjusted EBITDA and 10.3x adjusted OpFCF after taking into consideration revenue, cost and capital expenditure synergies (net of upgrade costs), or 10.0x adjusted EBITDA and 17.6x adjusted OpFCF before synergies. The tender offer is expected to commence by the end of August. Combination will create the leading national converged challenger in Switzerland. Together, the combined business would have CHF3.1 billion in revenue, 2.1 million mobile post-paid subscribers, 1.2 million broadband subscribers and 1.3 million TV subscribers, reflecting approximately 30% market share in each segment. Under the terms of a transaction agreement between Liberty Global and Sunrise, Liberty Global has published a pre-announcement today for an all cash public tender offer for all publicly held shares of Sunrise at a price of CHF110 per share. Liberty Global plans to fund the transaction through a combination of approximately CHF3.5 billion of cash from its balance sheet and approximately CHF3.2 billion of financing, of which CHF1.6 billion will be available to refinance existing indebtedness of Sunrise as needed. Upon becoming a wholly-owned subsidiary of Liberty Global, Sunrise will become part of the UPC credit pool. Targeted leverage for this pool will be 5.0x, pro forma for this transaction, including vendor financing and leases."

LBTYA

Liberty Global

$22.05 /

-0.13 (-0.59%)

LBTYK

Liberty Global

$21.45 /

-0.16 (-0.74%)

  • 10

    Sep

LBTYA Liberty Global
$22.05 /

-0.13 (-0.59%)

07/20/20 Pivotal Research
Liberty Global price target raised to $30 from $27 at Pivotal Research
07/15/20 Jefferies
Liberty Global price target raised to $25.70 from $18 at Jefferies
07/02/20 Redburn
Liberty Global upgraded to Buy from Neutral at Redburn
06/10/20 Deutsche Bank
Liberty Global price target raised to $38 from $30 at Deutsche Bank
LBTYK Liberty Global
$21.45 /

-0.16 (-0.74%)

TODAY'S FREE FLY STORIES

Initiation
TTM Technologies initiated with an Outperform at SMBC Nikko » 05:08
09/21/20
09/21
05:08
09/21/20
05:08
TTMI

TTM Technologies

$11.44 /

-0.01 (-0.09%)

SMBC Nikko initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TTMI TTM Technologies
$11.44 /

-0.01 (-0.09%)

TTMI TTM Technologies
$11.44 /

-0.01 (-0.09%)

07/02/20 Needham
TTM Technologies upgraded to Buy from Hold at Needham
07/02/20 Needham
TTM Technologies upgraded to Buy from Hold at Needham
03/11/20 JPMorgan
JPMorgan downgrades TTM Technologies to Neutral, prefers others in space
03/11/20 JPMorgan
TTM Technologies downgraded to Neutral from Overweight at JPMorgan
TTMI TTM Technologies
$11.44 /

-0.01 (-0.09%)

Upgrade
Portland General Electric upgraded to Buy from Neutral at Mizuho » 05:07
09/21/20
09/21
05:07
09/21/20
05:07
POR

Portland General Electric

$35.01 /

-0.3 (-0.85%)

Mizuho analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
POR Portland General Electric
$35.01 /

-0.3 (-0.85%)

POR Portland General Electric
$35.01 /

-0.3 (-0.85%)

09/16/20 BofA
Portland General Electric upgraded to Buy from Neutral at BofA
09/10/20 Guggenheim
Portland General says no indications of equipment causing fires, says Guggenheim
08/25/20 Seibert Williams
Portland General Electric upgraded to Buy from Hold at Seibert Williams
08/25/20 BofA
Portland General Electric downgraded to Neutral from Buy at BofA
POR Portland General Electric
$35.01 /

-0.3 (-0.85%)

POR Portland General Electric
$35.01 /

-0.3 (-0.85%)

Initiation
Rentokil initiated with a Sell at UBS » 05:06
09/21/20
09/21
05:06
09/21/20
05:06
RTOKY

Rentokil

$0.00 /

+ (+0.00%)

UBS analyst Nicole Manion…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RTOKY Rentokil
$0.00 /

+ (+0.00%)

08/27/20 Morgan Stanley
Rentokil price target raised to 620 GBp from 590 GBp at Morgan Stanley
08/07/20 JPMorgan
Rentokil price target raised to 570 GBp from 560 GBp at JPMorgan
08/03/20 Morgan Stanley
Rentokil price target raised to 590 GBp from 540 GBp at Morgan Stanley
07/24/20 Deutsche Bank
Rentokil price target raised to 550 GBp from 390 GBp at Deutsche Bank
Upgrade
Oracle upgraded to Outperform from Sector Perform at RBC Capital » 05:04
09/21/20
09/21
05:04
09/21/20
05:04
ORCL

Oracle

$59.77 /

-0.43 (-0.71%)

RBC Capital analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORCL Oracle
$59.77 /

-0.43 (-0.71%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

09/14/20 Wells Fargo
Oracle deal with TikTok looks like 'win-win,' says Wells Fargo
09/11/20 Societe Generale
Oracle price target raised to $70 from $60 at Societe Generale
09/11/20 RBC Capital
Oracle price target raised to $60 from $51 at RBC Capital
09/11/20 BMO Capital
Oracle price target raised to $63 from $57 at BMO Capital
ORCL Oracle
$59.77 /

-0.43 (-0.71%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

Recommendations
Exelixis price target raised to $33 from $30 at Piper Sandler » 05:03
09/21/20
09/21
05:03
09/21/20
05:03
EXEL

Exelixis

$26.78 /

-0.16 (-0.59%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXEL Exelixis
$26.78 /

-0.16 (-0.59%)

EXEL Exelixis
$26.78 /

-0.16 (-0.59%)

06/30/20 Piper Sandler
Exelixis' 2/3 Phase III Contact studies underway, says Piper Sandler
05/14/20 SunTrust
Exelixis price target raised to $40 from $35 at SunTrust
05/13/20 Piper Sandler
Exelixis mCRPC data for CABOMETYX may accelerate approval, says Piper Sandler
05/06/20 Piper Sandler
Exelixis price target raised to $30 from $23 at Piper Sandler
EXEL Exelixis
$26.78 /

-0.16 (-0.59%)

EXEL Exelixis
$26.78 /

-0.16 (-0.59%)

EXEL Exelixis
$26.78 /

-0.16 (-0.59%)

Recommendations
H.C. Wainwright ups Vir target to $80, sees 'terrific buying opportunity' » 04:59
09/21/20
09/21
04:59
09/21/20
04:59
VIR

Vir Biotechnology

$32.66 /

+0.65 (+2.03%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Patrick Trucchio raised the firm's price target on Vir Biotechnology to $80 from $75 and keeps a Buy rating on the shares. The analyst says the company last week provided a "compelling update" at its Global Investor Conference. Since the emergency authorization of convalescent plasma for COVID-19 on August 23 in the U.S., Vir shares are down 38%, which creates a "terrific buying opportunity ahead of key data readouts," Trucchio tells investors in a research note. The analyst believes the company maintains a leading position in the Covid-19 monoclonal antibody race.

ShowHide Related Items >><<
VIR Vir Biotechnology
$32.66 /

+0.65 (+2.03%)

VIR Vir Biotechnology
$32.66 /

+0.65 (+2.03%)

09/14/20
Fly Intel: Top five analyst upgrades
09/14/20 Goldman Sachs
Vir Biotechnology upgraded to Buy from Neutral at Goldman Sachs
09/11/20 JPMorgan
Vir Biotechnology upgraded to Neutral ahead of catalysts at JPMorgan
09/11/20 JPMorgan
Vir Biotechnology upgraded to Neutral from Underweight at JPMorgan
VIR Vir Biotechnology
$32.66 /

+0.65 (+2.03%)

  • 08
    Jul
  • 11
    Oct
VIR Vir Biotechnology
$32.66 /

+0.65 (+2.03%)

VIR Vir Biotechnology
$32.66 /

+0.65 (+2.03%)

Initiation
Essent Group initiated with a Buy at Goldman Sachs » 04:56
09/21/20
09/21
04:56
09/21/20
04:56
ESNT

Essent Group

$37.20 /

-0.18 (-0.48%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESNT Essent Group
$37.20 /

-0.18 (-0.48%)

ESNT Essent Group
$37.20 /

-0.18 (-0.48%)

06/09/20 Keefe Bruyette
Essent Group downgraded to Market Perform from Outperform at Keefe Bruyette
06/03/20 Credit Suisse
Essent Group price target raised to $38 from $32 at Credit Suisse
06/01/20 Susquehanna
Essent Group price target lowered to $48 from $56 at Susquehanna
06/01/20 B. Riley FBR
B. Riley FBR upgrades Radian on better forbearance data trends
ESNT Essent Group
$37.20 /

-0.18 (-0.48%)

  • 29
    May
ESNT Essent Group
$37.20 /

-0.18 (-0.48%)

Recommendations
Mirati Therapeutics price target raised to $170 from $145 at Piper Sandler » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
MRTX

Mirati Therapeutics

$160.89 /

-1.11 (-0.69%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$160.89 /

-1.11 (-0.69%)

MRTX Mirati Therapeutics
$160.89 /

-1.11 (-0.69%)

09/18/20
Fly Intel: Top five analyst downgrades
09/18/20 Citi
Mirati Therapeutics downgraded to Neutral from Buy at Citi
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/17/20 H.C. Wainwright
Mirati Therapeutics price target raised to $185 from $163 at H.C. Wainwright
MRTX Mirati Therapeutics
$160.89 /

-1.11 (-0.69%)

  • 10
    Jan
MRTX Mirati Therapeutics
$160.89 /

-1.11 (-0.69%)

Conference/Events
Inventiva participates in a webinar with Roth Capital » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
IVA

Inventiva

$11.62 /

-0.48 (-3.97%)

Biotech Analyst Jallah…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IVA Inventiva
$11.62 /

-0.48 (-3.97%)

08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
08/04/20
Fly Intel: Top five analyst initiations
  • 10
    Jul
Conference/Events
Duke Energy participates in a conference call with Wolfe Research » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
DUK

Duke Energy

$82.94 /

-1.69 (-2.00%)

Utilities & Power…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DUK Duke Energy
$82.94 /

-1.69 (-2.00%)

DUK Duke Energy
$82.94 /

-1.69 (-2.00%)

09/09/20 BofA
Duke Energy upgraded to Buy from Neutral at BofA
09/09/20 BofA
Duke Energy upgraded to Buy from Neutral at BofA
07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
DUK Duke Energy
$82.94 /

-1.69 (-2.00%)

  • 19
    Nov
DUK Duke Energy
$82.94 /

-1.69 (-2.00%)

DUK Duke Energy
$82.94 /

-1.69 (-2.00%)

DUK Duke Energy
$82.94 /

-1.69 (-2.00%)

Conference/Events
Royal Caribbean participates in a conference call hosted by Wolfe Reseach » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
RCL

Royal Caribbean

$65.40 /

-3.445 (-5.00%)

Wolfe Research Consumer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCL Royal Caribbean
$65.40 /

-3.445 (-5.00%)

RCL Royal Caribbean
$65.40 /

-3.445 (-5.00%)

08/25/20 Argus
Argus widens Royal Caribbean expected earnings losses
08/12/20 Credit Suisse
Royal Caribbean price target raised to $75 from $67 at Credit Suisse
08/11/20 JPMorgan
Royal Caribbean price target lowered to $67 from $72 at JPMorgan
08/11/20 Stifel
Royal Caribbean price target lowered to $72 from $85 at Stifel
RCL Royal Caribbean
$65.40 /

-3.445 (-5.00%)

RCL Royal Caribbean
$65.40 /

-3.445 (-5.00%)

RCL Royal Caribbean
$65.40 /

-3.445 (-5.00%)

RCL Royal Caribbean
$65.40 /

-3.445 (-5.00%)

Conference/Events
Beam Global management to meet virtually with BTIG » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
BEEM

Beam Global

$12.92 /

+0.08 (+0.62%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BEEM Beam Global
$12.92 /

+0.08 (+0.62%)

Conference/Events
UPS management to meet virtually with KeyBanc » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
UPS

UPS

$159.66 /

-0.13 (-0.08%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UPS UPS
$159.66 /

-0.13 (-0.08%)

UPS UPS
$159.66 /

-0.13 (-0.08%)

09/17/20 Deutsche Bank
FedEx price target raised to $243 from $150 at Deutsche Bank
09/03/20
Fly Intel: Top five analyst downgrades
09/03/20 Berenberg
Berenberg sees 'parcel pair trade,' raises FedEx to Buy and cuts UPS to Sell
09/03/20 Berenberg
UPS downgraded to Sell from Hold at Berenberg
UPS UPS
$159.66 /

-0.13 (-0.08%)

UPS UPS
$159.66 /

-0.13 (-0.08%)

UPS UPS
$159.66 /

-0.13 (-0.08%)

UPS UPS
$159.66 /

-0.13 (-0.08%)

General news
Dallas Federal Reserve Bank President Robert Kaplan Speech to be released at 18:00  04:55
09/21/20
09/21
04:55
09/21/20
04:55
 
General news
6-Month Bill Auction to be released at 11:30  04:55
09/21/20
09/21
04:55
09/21/20
04:55
 
General news
Chicago Fed National Activity Index to be reported at 08:30 » 04:55
09/21/20
09/21
04:55
09/21/20
04:55

August Chicago Fed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
3-Month Bill Auction to be released at 11:30  04:55
09/21/20
09/21
04:55
09/21/20
04:55
 
General news
New York Federal Reserve Bank John Williams Speech to be released at 18:00  04:55
09/21/20
09/21
04:55
09/21/20
04:55
 
Conference/Events
Option Care Health management to virtually meet with Barrington » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
OPCH

Option Care Health

$11.79 /

+0.61 (+5.46%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPCH Option Care Health
$11.79 /

+0.61 (+5.46%)

OPCH Option Care Health
$11.79 /

+0.61 (+5.46%)

08/05/20 Barrington
Option Care Health price target raised to $19 from $17 at Barrington
07/27/20 Lake Street
Option Care Health weakness a buying opportunity, says Lake Street
06/29/20 Lake Street
Option Care Health should be bought on S-3 filing dip, says Lake Street
06/24/20 BofA
Option Care Health initiated with a Buy at BofA
OPCH Option Care Health
$11.79 /

+0.61 (+5.46%)

  • 22
    Jul
OPCH Option Care Health
$11.79 /

+0.61 (+5.46%)

Conference/Events
Cimpress management to meet virtually with Truist » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
CMPR

Cimpress

$77.07 /

-3.49 (-4.33%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMPR Cimpress
$77.07 /

-3.49 (-4.33%)

CMPR Cimpress
$77.07 /

-3.49 (-4.33%)

08/17/20 Barrington
Cimpress upgraded to Outperform from Market Perform at Barrington
07/30/20 SunTrust
Cimpress upgraded to Buy from Hold at SunTrust
07/30/20 SunTrust
Cimpress upgraded to Buy from Hold at SunTrust
03/27/20 SunTrust
Cimpress price target lowered to $68 from $130 at SunTrust
CMPR Cimpress
$77.07 /

-3.49 (-4.33%)

CMPR Cimpress
$77.07 /

-3.49 (-4.33%)

Conference/Events
Benchmark tech analyst to hold an analyst/industry conference call » 04:55
09/21/20
09/21
04:55
09/21/20
04:55

Technology Analyst Jiang,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Insteel management to meet virtually with B. Riley FBR » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
IIIN

Insteel

$19.00 /

-0.08 (-0.42%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IIIN Insteel
$19.00 /

-0.08 (-0.42%)

IIIN Insteel
$19.00 /

-0.08 (-0.42%)

06/10/20 Sidoti
Insteel downgraded to Neutral from Buy at Sidoti
03/17/20 Sidoti
Insteel upgraded to Buy from Neutral at Sidoti
01/22/20 Sidoti
Insteel downgraded to Neutral from Buy at Sidoti
01/17/20 Kansas City Capital
Insteel downgraded to Perform from Outperform at Kansas City Capital
IIIN Insteel
$19.00 /

-0.08 (-0.42%)

Conference/Events
SI-Bone management to meet virtually with JMP Securities » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
SIBN

SI-Bone

$24.28 /

+0.65 (+2.75%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIBN SI-Bone
$24.28 /

+0.65 (+2.75%)

SIBN SI-Bone
$24.28 /

+0.65 (+2.75%)

06/16/20 Cantor Fitzgerald
SI-Bone assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
SI-Bone assumed with an Overweight at Cantor Fitzgerald
03/10/20 Morgan Stanley
SI-Bone EPS estimates cut at Morgan Stanley
03/10/20 Canaccord
SI-Bone fundamentals remain intact despite macro weakness, says Canaccord
SIBN SI-Bone
$24.28 /

+0.65 (+2.75%)

  • 23
    Jan
Conference/Events
Amgen to host business news update conference call » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
AMGN

Amgen

$248.01 /

-0.22 (-0.09%)

Management provides an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$248.01 /

-0.22 (-0.09%)

AMGN Amgen
$248.01 /

-0.22 (-0.09%)

09/20/20 Piper Sandler
Amgen's sotorasib update 'Incrementally positive,' says Piper Sandler
09/18/20 Piper Sandler
Amgen sotosarib Phase 1 data a good news/bad news event, says Piper Sandler
09/01/20 Jefferies
Checkmate Pharmaceuticals initiated with a Buy at Jefferies
07/29/20 Piper Sandler
Piper says AbbVie's atogepant 'may yet emerge as best in class'
AMGN Amgen
$248.01 /

-0.22 (-0.09%)

AMGN Amgen
$248.01 /

-0.22 (-0.09%)

AMGN Amgen
$248.01 /

-0.22 (-0.09%)

AMGN Amgen
$248.01 /

-0.22 (-0.09%)

Conference/Events
Jefferies biotech analyst to hold an analyst/industry conference call » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
IMMU

Immunomedics

$85.50 /

+0.19 (+0.22%)

, GILD

Gilead

$65.05 /

+0.03 (+0.05%)

Biotech Analyst Howerton,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/20/20 Piper Sandler
Immunomedics ASCENT data 'an absolute slam dunk,' says Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/17/20 Piper Sandler
Novocure price target raised to $125 from $89 at Piper Sandler
GILD Gilead
$65.05 /

+0.03 (+0.05%)

09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/18/20 RBC Capital
Gilead price target raised to $86 from $82 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 Maxim
Gilead upgraded to Buy at Maxim following Immunomedics deal
IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

  • 29
    Apr
  • 05
    Dec
IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.